A.H.A. committee report. Prevention of rheumatic fever.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial; D004697:Endocarditis, Bacterial / Q000517:prevention & control; D006801:Humans; D010400:Penicillin G / Q000627:therapeutic use; D010401:Penicillin G Benzathine / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D010614:Pharynx / Q000382:microbiology; D012008:Recurrence; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012213:Rheumatic Fever / Q000209:etiology / Q000517:prevention & control* / Q000635:transmission; D013290:Streptococcal Infections / Q000175:diagnosis / Q000188:drug therapy; D013291:Streptococcus / Q000276:immunology; D013411:Sulfadiazine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D010406:Penicillins; D013411:Sulfadiazine; D010400:Penicillin G; D010401:Penicillin G Benzathine